The U.S. Food and Drug Administration today approved Onsolis, medication intended for certain patients with cancer to help manage breakthrough pain – severe flares of pain that break through regular pain medication.
See the article here:
FDA Approves Opioid Pain Reliever with Required Risk Reduction Plan